Search

Tracey L Colpitts

from Round Lake, IL
Age ~62
Get Report
Also known as:
Tracey L Copitts, Tracy L Colpitts, Tracey L Kolpitts, Tracey L C Menhart, Tracey L Menhart, Tracey L Coltitts
Phone and address:
34365 Circle Ct, Volo, IL 60073
(847) 548-6451
Related to:
Rachel E Menhart, 28Nick G Menhart, 60Mary H Menhart, 30
Connected to:
Catherine A Colpitts, 69Francis A Colpitts, 76Jessica L Colpitts, 39Marlene S Colpitts, 84Micheal R Colpitts, 76Nathan Colpitts, 47Susan K Colpo, 67Marisa E Colpoys, 32Patrick J Colpoys, 70Roseanne J Colpoys, 63

Tracey Colpitts Phones & Addresses

  • 34365 Circle Ct, Round Lake, IL 60073 (847) 548-6451
  • 34365 Circle Dr, Round Lake, IL 60073
  • Grayslake, IL
  • Madison, WI
  • South Bend, IN

Work

Company: Abbott Jan 2012 to Jan 2015 Position: Director, technology assessment and new leads for corporate development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Notre Dame Specialities: Biochemistry, Chemistry

Skills

Genomics • Lifesciences • Medical Devices • Pharmaceutical Industry • Assay Development • Fda • Clinical Diagnostics • Biomarkers • Companion Diagnostics • Translational Medicine • Oncology • Biotechnology • Infectious Diseases • R&D • Life Sciences • Cross Functional Team Leadership • Medical Diagnostics • Commercialization • Hardware Diagnostics

Industries

Medical Devices

Resumes

Resumes

Tracey Colpitts Photo 1

Tracey Colpitts

View page
Location:
Chicago, IL
Industry:
Medical Devices
Work:
Abbott Jan 2012 - Jan 2015
Director, Technology Assessment and New Leads For Corporate Development
Education:
University of Notre Dame
Doctorates, Doctor of Philosophy, Biochemistry, Chemistry
Skills:
Genomics
Lifesciences
Medical Devices
Pharmaceutical Industry
Assay Development
Fda
Clinical Diagnostics
Biomarkers
Companion Diagnostics
Translational Medicine
Oncology
Biotechnology
Infectious Diseases
R&D
Life Sciences
Cross Functional Team Leadership
Medical Diagnostics
Commercialization
Hardware Diagnostics

Publications

Us Patents

Reagents And Methods Useful For Detecting Diseases Of The Prostate

View page
US Patent:
6350583, Feb 26, 2002
Filed:
May 8, 2000
Appl. No.:
09/566876
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Edward N. Granados - Vernon Hills IL
Michael R. Klass - Libertyville IL
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
G01N 3353
US Classification:
435 71, 435 4, 435 721, 435 723, 435 792, 436512, 436536, 530350, 530385, 5303871, 5303877, 5303879, 5303881, 53038815, 5303891, 5303897
Abstract:
A set of contiguous and partially overlapping RNA sequences and polypeptides encoded thereby, designated as PS190 and transcribed from prostate tissue is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which specifically bind to PS190-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific PS190 polypeptide, which molecules are useful for the therapeutic treatment of prostate diseases, tumors or metastases.

Reagents And Methods Useful For Detecting Diseases Of The Gastrointestinal Tract

View page
US Patent:
6368792, Apr 9, 2002
Filed:
Mar 27, 1998
Appl. No.:
09/049698
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Mark Hayden - Ingleside IL
Michael R. Klass - Libertyville IL
John C. Russell - Kenosha WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 4353201, 435325, 435352, 435363, 435366, 4352523, 536 231
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS193 and transcribed from GI tract tissue, are described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS193-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS193 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Reagents And Methods Useful For Detecting Diseases Of The Prostate

View page
US Patent:
6391543, May 21, 2002
Filed:
Apr 23, 1998
Appl. No.:
09/065383
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Julian Gordon - Lake Bluff IL
Edward N. Granados - Vernon Hills IL
Steven C. Hodges - Buffalo Grove IL
Michael R. Klass - Libertyville IL
Jon D. Kratochvil - Kenosha WI
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12Q 168
US Classification:
435 6, 4352402, 4353201, 536 231, 536 243, 536 2431, 536 2432, 536 2433
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as PS118 and transcribed from prostate tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which specifically bind to PS118-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific PS118 polypeptide, which molecules are useful for the therapeutic treatment of prostate diseases, tumors or metastases.

Reagents And Methods Useful For Detecting Diseases Of The Prostate

View page
US Patent:
6465181, Oct 15, 2002
Filed:
Mar 25, 1999
Appl. No.:
09/276600
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Julian Gordon - Lake Bluff IL
Edward N. Granados - Vernon Hills IL
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 435 915, 536 221, 536 235, 536 2431, 536 2433
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as PCIGF and transcribed from prostate tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which specifically bind to PCIGF-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific PCIGF polypeptide, which molecules are useful for the therapeutic treatment of prostate diseases, tumors or metastases.

Reagents And Methods Useful For Detecting Diseases Of The Breast

View page
US Patent:
6538119, Mar 25, 2003
Filed:
Nov 18, 1998
Appl. No.:
09/193881
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Edward N. Granados - Vernon Hills IL
Michael R. Klass - Libertyville IL
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07H 2102
US Classification:
536 231, 435 691, 4353201, 530350
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as BS249 and transcribed from breast tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the breast, such as breast cancer. Also provided are antibodies which specifically bind to BS249-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BS249 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases.

Reagents Useful For Detecting Diseases Of The Gastrointestinal Tract

View page
US Patent:
6627414, Sep 30, 2003
Filed:
Mar 30, 1998
Appl. No.:
09/050516
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Julian Gordon - Lake Bluff IL
Edward N. Granados - Vernon Hills IL
Mark A. Hayden - Ingleside IL
Steven C. Hodges - Buffalo Grove IL
Michael R. Klass - Libertyville IL
Jon D. Kratochvil - Wildwood MO
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12P 2106
US Classification:
435 691, 435 6, 4352523, 4353201, 435325, 536 235, 536 2431
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS 198 and transcribed from GI tract tissue, is described. These sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS 198-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS 198 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Reagents Useful For Detecting Diseases Of The Gastrointestinal Tract

View page
US Patent:
6660834, Dec 9, 2003
Filed:
Oct 23, 2002
Appl. No.:
10/278547
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Julian Gordon - Lake Bluff IL
Edward N. Granados - Vernon Hills IL
Mark A. Hayden - Ingleside IL
Steven C. Hodges - Buffalo Grove IL
Michael R. Klass - Libertyville IL
Jon D. Kratochvil - Wildwood MO
John C. Russell - Pleasant Prairie WI
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 1447
US Classification:
530324, 530350, 530828, 435810
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS198 and transcribed from GI tract tissue, is described. These sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS198-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS198 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Reagents And Methods Useful For Detecting Diseases Of The Breast

View page
US Patent:
6770435, Aug 3, 2004
Filed:
Nov 1, 1999
Appl. No.:
09/431384
Inventors:
Maurice Cohen - Highland Park IL
Tracey L. Colpitts - Round Lake IL
Paula N. Friedman - Deerfield IL
Julian Gordon - Lake Bluff IL
Edward N. Granados - Vernon Hills IL
Steven C. Hodges - Buffalo Grove IL
Michael R. Klass - Libertyville IL
Jon D. Kratochvil - Wildwood MO
John C. Russell - Pleasant Prairie WI
Christi P. Scheffel - Mundelein IL
Stephen D. Stroupe - Libertyville IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C12Q 168
US Classification:
435 6, 435 724, 435 94, 536 231, 536 243, 436501, 436504
Abstract:
A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as BU101 and transcribed from breast tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the breast, such as breast cancer. Also provided are antibodies which specifically bind to BU101-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BU101 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases.
Control profile
Tracey L Colpitts from Round Lake, IL, age ~62 Get Report